STEPHEN RUBINO, PH.D., M.B.A.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Viracta Therapeutics, Inc.

Filing Date Source Excerpt
2022-04-27 The following table sets forth the names, ages as of April 19, 2022, and certain other information for each of our directors and director nominees: Stephen Rubino, Ph.D., M.B.A., Director, Age 63, Director since 2021. Member of audit committee, nominating and corporate governance committee, and science and technology committee. Director Compensation table shows total compensation of $566,499.
2023-04-27 Dr. Rubino has served as a member of the board of directors since March 2021. ... Member of audit committee, Member of nominating and corporate governance committee, Member of science and technology committee. Director Compensation: Stephen Rubino, Ph.D., M.B.A. - Total ($) 153,700.
2024-04-26 Dr. Rubino has served as a member of the board of directors since March 2021. ... Dr. Rubino received a Ph.D. in virology from Cornell University and an M.B.A. from Baruch College. ... The following table sets forth information regarding the total compensation awarded to, earned by or paid to our non-employee directors for their service on our board of directors, for the fiscal year ended December 31, 2023. ... Stephen Rubino, Ph.D., M.B.A. Fees Paid or Earned in Cash ($) 62,500 Option Awards($) 45,755 Total ($) 108,255 ... The current members of our audit committee are Mr. Darcy, Dr. Rubino, and Dr. Simon. ... The current members of our nominating and corporate governance committee are Dr. Rubino, Dr. Barlow, Ms. Chung and Dr. Murphy. ... The current members of our science and technology committee are Dr. Borellini, Dr. Murphy, Dr. Royston and Dr. Rubino.

Data sourced from SEC filings. Last updated: 2026-03-09